| Levosimendan and severe pulmonary hypertension during open heart surgery. | |
| | |
MedLine Citation:
|
PMID: 19002758 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Weaning from cardiopulmonary bypass is the most important stage during mitral valve surgery, especially in patients with severe pulmonary hypertension. We report two patients with severe pulmonary hypertension who were operated on because of valvular heart disease. To reduce the pulmonary artery pressure, levosimendan was used because of its vasodilatory and cytoprotective effects. All patients tolerated the operation and levosimendan administration. Their postoperative course was uneventful. Levosimendan can be used to treat pulmonary hypertension during operations for heart valve disease. Patients clearly benefit from the vasodilator action of the drug for reducing pulmonary artery pressure. |
| | |
Authors:
|
Ferit Cicekcioglu; Ali Ihsan Parlar; Ozgur Ersoy; Kerem Yay; Alaa Hijazi; S Fehmi Katircioglu |
Related Documents
:
|
7960268 - Pulmonary artery aneurysm associated with hereditary hemorrhagic telangiectasia. 23231768 - Modified technique for reconstructing the visceral arteries in thoracoabdominal aortic ... 18595578 - Chronic thromboembolic pulmonary hypertension as an uncommon presentation of primary an... 2632758 - Forearm vasodilatory capacity in patients with syndrome x: a comparison with normal and... 1019638 - Basilic vein to brachial artery fistula: a new access for chronic hemodialysis. 16775448 - Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathoge... |
Publication Detail:
|
Type: Case Reports; Comparative Study; Journal Article Date: 2008-11-12 |
Journal Detail:
|
Title: General thoracic and cardiovascular surgery Volume: 56 ISSN: 1863-6705 ISO Abbreviation: - Publication Date: 2008 Nov |
Date Detail:
|
Created Date: 2008-11-12 Completed Date: 2009-01-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101303952 Medline TA: Gen Thorac Cardiovasc Surg Country: Japan |
Other Details:
|
Languages: eng Pagination: 563-5 Citation Subset: IM |
Affiliation:
|
Kalp ve Damar Cerrahisi Klinigi (Cardiovascular Surgery Clinic), Turkiye Yuksek Ihtisas Hastanesi, Sihhiye, Ankara 06100, Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiac Surgical Procedures* Female Follow-Up Studies Heart Valve Diseases / surgery* Heart Valve Prosthesis Implantation Humans Hydrazones / administration & dosage, therapeutic use* Hypertension, Pulmonary / drug therapy* Middle Aged Pyridazines / administration & dosage, therapeutic use* Time Factors Treatment Outcome Vasodilator Agents / administration & dosage, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Hydrazones; 0/Pyridazines; 0/Vasodilator Agents; 131741-08-7/simendan |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tricuspid valve replacement and levosimendan.
Next Document: Large-cell neuroendocrine carcinoma in the thymus.